Weakening the virus

Israeli-UK biotech Eleven Therapeutics is developing RNAi therapy that attacks the genetic structure of respiratory viruses such as SARS-COV-2. Eleven has just received a $9 million grant from the Gates Foundation.



This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *